These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38546342)

  • 1. A low bleeding risk thrombolytic agent: citPA5.
    Chen S; Fang S; Zhou Y; Huang Z; Yu S; Chen D; Wang Z; Xu Y; Liu P; Li Y; Lin W; Jiang L; Yuan C; Huang M
    Cardiovasc Res; 2024 Sep; 120(10):1191-1201. PubMed ID: 38546342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A triple fusion tissue-type plasminogen activator (TriF-ΔtPA) enhanced thrombolysis in carotid embolism-induced stroke model.
    Xu Y; Chen D; Liu P; Hu Y; Peng S; Chen S; Li Y; Lin W; Jiang L; Yuan C; Huang M
    Int J Pharm; 2023 Apr; 637():122878. PubMed ID: 36958614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleeding.
    Thomas GR; Thibodeaux H; Errett CJ; Badillo JM; Keyt BA; Refino CJ; Zivin JA; Bennett WF
    Stroke; 1994 Oct; 25(10):2072-8; discussion 2078-9. PubMed ID: 8091454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. tPA Point Mutation at Autolysis Loop Enhances Resistance to PAI-1 Inhibition and Catalytic Activity.
    Peng S; Xue G; Chen S; Chen Z; Yuan C; Li J; Huang M
    Thromb Haemost; 2019 Jan; 119(1):77-86. PubMed ID: 30597502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mouse dorsal skinfold chamber as a model for the study of thrombolysis by intravital microscopy.
    Boulaftali Y; Lamrani L; Rouzaud MC; Loyau S; Jandrot-Perrus M; Bouton MC; Ho-Tin-Noé B
    Thromb Haemost; 2012 May; 107(5):962-71. PubMed ID: 22552380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke.
    Wardlaw JM; Koumellis P; Liu M
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD000514. PubMed ID: 23728633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-type plasminogen activator-binding RNA aptamers inhibiting low-density lipoprotein receptor family-mediated internalisation.
    Bjerregaard N; Bøtkjær KA; Helsen N; Andreasen PA; Dupont DM
    Thromb Haemost; 2015 Jul; 114(1):139-49. PubMed ID: 25855589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced clot lysis by a single point mutation in a reteplase variant.
    Chen S; Chen D; Liu Y; Xu Y; Lin H; Cheng Y; Li J; Meng C; Liang M; Yuan C; Huang M
    Br J Haematol; 2022 Feb; 196(4):1076-1085. PubMed ID: 34783361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models.
    Nisar T; Hanumanthu R; Khandelwal P
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104360. PubMed ID: 31501036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhage.
    Stewart D; Kong M; Novokhatny V; Jesmok G; Marder VJ
    Blood; 2003 Apr; 101(8):3002-7. PubMed ID: 12446443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly(Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy.
    Chen HA; Ma YH; Hsu TY; Chen JP
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32294917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator.
    Ribo M; Montaner J; Molina CA; Arenillas JF; Santamarina E; Quintana M; Alvarez-Sabín J
    Stroke; 2004 Sep; 35(9):2123-7. PubMed ID: 15243150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O2L-001, an innovative thrombolytic to evacuate intracerebral haematoma.
    Thiebaut AM; Louet ER; Ianszen M; Guichard MJ; Hanley DF; Gaudin C; Parcq J
    Brain; 2023 Nov; 146(11):4690-4701. PubMed ID: 37450572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The iScore predicts efficacy and risk of bleeding in the National Institute of Neurological disorders and Stroke Tissue Plasminogen Activator Stroke Trial.
    Saposnik G; Demchuk A; Tu JV; Johnston SC;
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):876-82. PubMed ID: 23102741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prourokinase mutant that induces highly effective clot lysis without interfering with hemostasis.
    Liu JN; Liu JX; Liu Bf BF; Sun Z; Zuo JL; Zhang Px PX; Zhang J; Chen Yh YH; Gurewich V
    Circ Res; 2002 Apr; 90(7):757-63. PubMed ID: 11964367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism.
    Orbe J; Barrenetxe J; Rodriguez JA; Vivien D; Orset C; Parks WC; Birkland TP; Serrano R; Purroy A; Martinez de Lizarrondo S; Angles-Cano E; Páramo JA
    Circulation; 2011 Dec; 124(25):2909-19. PubMed ID: 22104553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of TAFI increases brain damage and microparticle generation after thrombolytic therapy in ischemic stroke.
    Orbe J; Alexandru N; Roncal C; Belzunce M; Bibiot P; Rodriguez JA; Meijers JC; Georgescu A; Paramo JA
    Thromb Res; 2015 Aug; 136(2):445-50. PubMed ID: 26118976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel and emerging therapies: thrombus-targeted fibrinolysis.
    Lippi G; Mattiuzzi C; Favaloro EJ
    Semin Thromb Hemost; 2013 Feb; 39(1):48-58. PubMed ID: 23034825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis by chemically modified coagulation factor Xa.
    Pryzdial EL; Meixner SC; Talbot K; Eltringham-Smith LJ; Baylis JR; Lee FM; Kastrup CJ; Sheffield WP
    J Thromb Haemost; 2016 Sep; 14(9):1844-54. PubMed ID: 27359348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.